BBNX (Beta Bionics) Research & Development: $37.6 Mil (TTM As of Mar. 2026)


BBNX Beta Bionics Inc BBNX
10 GF Score
Price $17.00
! 3 Warning Signs
View Full Analysis

What is Beta Bionics Research & Development?

Beta Bionics BBNX +1.71% 10 Research & Development is $37.6 Mil as of Mar. 2026. GuruFocus rates BBNX with a GF Score™ of 10/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Beta Bionics's Research & Development for the three months ended in Mar. 2026 was $10.4 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $37.6 Mil.

Beta Bionics  (NAS:BBNX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Beta Bionics Research & Development Related Terms

Beta Bionics Research & Development Historical Data

* Premium members only.

The historical data trend for Beta Bionics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Bionics Research & Development Chart

Beta Bionics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
31.43 17.94 26.18 34.79

Beta Bionics Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 7.59 8.87 8.20 10.13 10.36
BBNX
10GF Score
Beta Bionics Inc BBNX
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beta Bionics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $37.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $37.6 Mil mean?
Beta Bionics (BBNX) has a Research & Development of $37.6 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Beta Bionics and its competitors.
Is Beta Bionics' Research & Development too high?
Beta Bionics' current Research & Development is $37.6 Mil. Overall, Beta Bionics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Beta Bionics' Research & Development compare to CBLL and SIBN?
Beta Bionics' Research & Development of $37.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Beta Bionics and its competitors. Beta Bionics's current Research & Development is $37.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Bionics stock overvalued right now?
Beta Bionics (BBNX) has a current Research & Development of $37.6 Mil. The current Research & Development is $37.6 Mil. Beta Bionics' overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Beta Bionics (BBNX), the current Research & Development is $37.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beta Bionics Business Description

Address 11 Hughes, Irvine, CA, USA, 92618
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
10GF Score

Get the complete analysis for BBNX

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.00
Price